Track: Neuropharmacology and Neuroendocrinology

Neuroscience conference 2026

Advances in Neuropharmacology

Novel pharmacological targets for treating neurological and psychiatric disorders.

Development and challenges of biologics in neurology, including monoclonal antibodies.


Neurotransmitters and Synaptic Function

The role of neurotransmitter systems in brain health and disease.

Modulating synaptic activity through pharmacological interventions.


Endocrine Regulation of Brain Function

Hormonal influences on cognition, mood, and behavior.

Neuroendocrine factors in aging and neurodegenerative diseases.


Stress, HPA Axis Dysregulation, and Mental Health

The role of the hypothalamic-pituitary-adrenal (HPA) axis in stress response.

Neuropharmacological approaches to treating stress-related disorders.


Neuroendocrine Tumors and Disorders

Advances in understanding and treating pituitary and hypothalamic disorders.

Neuroendocrine aspects of conditions like Cushing's disease and acromegaly.


Pharmacogenomics in Neurology

Personalized medicine in neuropharmacology: genetic predictors of drug response.

Epigenetic mechanisms influencing drug efficacy and safety.


The Gut-Brain-Endocrine Axis

Interactions between gut microbiota, hormones, and brain function.

Exploring therapeutic potential of microbiome modulation in neuroendocrine disorders.


Emerging Therapies in Neuropharmacology and Neuroendocrinology

Applications of neurosteroids and peptide-based drugs.

Cutting-edge research in hormone replacement therapies for brain disorders.